Zoetis Inc. (NYSE:ZTS) – Jefferies Group issued their Q3 2016 earnings per share (EPS) estimates for Zoetis in a report released on Thursday. Jefferies Group analyst J. Holford forecasts that the firm will earn $0.46 per share for the quarter. Jefferies Group currently has a “Buy” rating and a $60.00 target price on the stock. Jefferies Group also issued estimates for Zoetis’ FY2016 earnings at $1.90 EPS.

Zoetis (NYSE:ZTS) last issued its quarterly earnings data on Wednesday, August 3rd. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.44 by $0.05. Zoetis had a net margin of 13.15% and a return on equity of 77.58%. The company had revenue of $1.20 billion for the quarter, compared to analysts’ expectations of $1.17 billion. During the same quarter in the previous year, the firm posted $0.43 earnings per share. Zoetis’s revenue for the quarter was up 2.8% on a year-over-year basis.

Earnings History and Estimates for Zoetis (NYSE:ZTS)

Several other research analysts also recently commented on the stock. Bank of America Corp. started coverage on shares of Zoetis in a report on Thursday, September 29th. They issued a “buy” rating and a $60.00 price objective for the company. Credit Suisse Group AG reiterated an “outperform” rating and issued a $60.00 target price on shares of Zoetis in a research note on Tuesday, August 23rd. Argus increased their target price on shares of Zoetis from $54.00 to $58.00 and gave the stock a “below average” rating in a research note on Friday, September 9th. Zacks Investment Research cut shares of Zoetis from a “buy” rating to a “hold” rating in a research note on Thursday, October 6th. Finally, Guggenheim reiterated a “positive” rating and issued a $60.00 target price on shares of Zoetis in a research note on Monday, August 22nd. Three equities research analysts have rated the stock with a sell rating, two have issued a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $55.27.

Shares of Zoetis (NYSE:ZTS) opened at 50.18 on Friday. Zoetis has a 52 week low of $38.26 and a 52 week high of $53.14. The company has a 50 day moving average of $51.25 and a 200 day moving average of $49.01. The company has a market cap of $24.84 billion, a PE ratio of 39.08 and a beta of 1.01.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 1st. Investors of record on Thursday, November 3rd will be given a $0.095 dividend. This represents a $0.38 dividend on an annualized basis and a yield of 0.76%. The ex-dividend date is Tuesday, November 1st. Zoetis’s payout ratio is presently 29.69%.

In other Zoetis news, insider Heidi C. Chen sold 32,097 shares of the firm’s stock in a transaction on Thursday, September 1st. The shares were sold at an average price of $50.98, for a total value of $1,636,305.06. Following the sale, the insider now owns 46,060 shares of the company’s stock, valued at approximately $2,348,138.80. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Michael B. Mccallister purchased 2,000 shares of the business’s stock in a transaction on Tuesday, September 6th. The stock was purchased at an average cost of $51.34 per share, for a total transaction of $102,680.00. The disclosure for this purchase can be found here. 0.05% of the stock is currently owned by corporate insiders.

A number of large investors have recently made changes to their positions in ZTS. Virginia Retirement System purchased a new stake in shares of Zoetis during the first quarter worth about $340,000. Franklin Resources Inc. raised its stake in shares of Zoetis by 18.4% in the first quarter. Franklin Resources Inc. now owns 76,090 shares of the company’s stock worth $3,374,000 after buying an additional 11,804 shares during the period. NN Investment Partners Holdings N.V. purchased a new stake in shares of Zoetis during the first quarter worth about $118,000. Bessemer Group Inc. raised its stake in shares of Zoetis by 323.2% in the first quarter. Bessemer Group Inc. now owns 5,066 shares of the company’s stock worth $225,000 after buying an additional 3,869 shares during the period. Finally, Advisor Partners LLC raised its stake in shares of Zoetis by 15.3% in the first quarter. Advisor Partners LLC now owns 5,548 shares of the company’s stock worth $246,000 after buying an additional 737 shares during the period. 93.12% of the stock is currently owned by institutional investors and hedge funds.

About Zoetis

Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a diversified business, marketing products across over eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock), and dogs, cats and horses (collectively, companion animals), and within over five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

5 Day Chart for NYSE:ZTS

Receive News & Stock Ratings for Zoetis Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis Inc. and related stocks with our FREE daily email newsletter.